Abstract:The inherent structural instability of some physalins has hampered the isolation and identification of these compounds for approximately 50 years, and an effective method to overcome these challenges remains unavailable. In the present study, the unprecedented tautomerization mechanism of unstable physalins was elucidated by performing isotopic labeling experiments and DFT calculations, which led to the successful separation of tautomers and isolation of highly pure products for the first time. As a result, 15 new physalins, physaminins A-O (1-15), as well as 17 known analogues (16-32), were isolated from the whole plants of Physalis minima L. The chemical structures of the new compounds were established by performing a comprehensive analysis of spectroscopic data, and their absolute configurations were confirmed by using computational ECD calculations and/or single-crystal X-ray diffraction analyses. All obtained isolates were evaluated for their antiproliferative effects against four human cancer cell lines (A549, HepG2, MCF-7, and SCG-7901) and two noncancerous cell lines (RAW 264.7 and human normal hepatocytes L02), as well as their anti-inflammatory activities by measuring their abilities to inhibit NO production in LPS-stimulated murine RAW 264.7 cells in vitro. Compounds 1-5, 13, 16, 18, 19, 23, and 30 exerted significant antiproliferative effects on the four human cancer lines, with IC50 values ranging from 0.2(0) to 24.7(2) μM, and these compounds were not toxic to the two noncancerous cell lines at a concentration of 10 μM. Moreover, compounds 7, 10, 11, 12, 14, 17, 22, and 27 significantly inhibited NO production, with IC50 values ranging from 2.9(1) to 9.5(2) μM.

Physalinol A, a 1,10-Seco-physalin with an Epidioxy from Physalis Alkekengi L. Var. Franchetii (mast.) Makino

Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors.

Unprecedent Aminophysalin from Physalis Angulata

Two New Physalins from Physalis Alkekengi L. Var. Franchetii (mast.) Makino.

Physalins V-IX, 16,24-cyclo-13,14-seco withanolides from Physalis angulata and their antiproliferative and anti-inflammatory activities

Physalins and Withanolides from the Fruits of Physalis Alkekengi L. Var. Franchetii (mast.) Makino and the Inhibitory Activities Against Human Tumor Cells

Six New Physalins from Physalis Alkekengi Var. Franchetii and Their Cytotoxicity and Antibacterial Activity.

Discovery of physalin biosynthesis and structure modification of physalins in Physalis alkekengi L. var. Franchetii

A Novel Cytotoxic Physalin from Physalis Angulata

Silencing Tautomerization to Isolate Unstable Physalins from <i>Physalis minima</i>

Chemical Constituents from Physalis alkekengi and Structural Revision of Physalin G

Two Sulfonate Metabolites of Physalin A in Rats

Silencing Tautomerization to Isolate Unstable Physalins from Physalis minima

Isolation and identification of physalins from Physalis alkekengi L. var. franchti (Mast.) Makino

Cytotoxic Physalins from Aeroponically Grown Physalis acutifolia

Withaphysalin-Type Withanolides from Physalis Minima

Characterization of physalins and fingerprint analysis for the quality evaluation of Physalis alkekengi L. var. franchetii by ultra-performance liquid chromatography combined with diode array detection and electrospray ionization tandem mass spectrometry.

The Rapid Discovery and Identification of Physalins in the Calyx of Physalis Alkekengi L.var.franchetii (mast.) Makino Using Ultra-High Performance Liquid Chromatography–quadrupole Time of Flight Tandem Mass Spectrometry Together with a Novel Three-Step Data Mining Strategy

Steroids and Flavonoids from Physalis Alkekengi Var. Franchetii and Their Inhibitory Effects on Nitric Oxide Production.

A pair of 3-epimeric physalins from Physalis alkekengi L. var. franchetii.

Naturally occurring physalins from the genus Physalis: A review